More tools:Markets·Screener·Research·Chat

RenovoRx, Inc. Common Stock (RNXT) Financial Statements

RenovoRx, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG005XWWZL5
XNAS · usd
2.20▼ 0.19 (-7.95%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close2.39
Day's Range2.15 – 2.35
52-Week Range0.70 – 2.59
Volume1.2M
Avg Volume1.0M
Share Statistics
Shares Outstanding
Employees17
ExchangeXNAS
Listed2021-08-26
Share count as of August 7, 2026
Loading Income Statement…
Key questions about RenovoRx, Inc. Common Stock (RNXT)
What is RenovoRx, Inc. Common Stock's Market Cap?
RenovoRx, Inc. Common Stock's Market Cap is $99.3M, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's Enterprise Value?
RenovoRx, Inc. Common Stock's Enterprise Value is $89.8M, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's Price / Sales?
RenovoRx, Inc. Common Stock's Price / Sales is 50.2×, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's EV / Revenue?
RenovoRx, Inc. Common Stock's EV / Revenue is 45.4×, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's EV / EBITDA?
RenovoRx, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's Revenue (TTM)?
RenovoRx, Inc. Common Stock's Revenue (TTM) is $2.0M, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's Net Income (TTM)?
RenovoRx, Inc. Common Stock's Net Income (TTM) is -$12.3M, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's EBITDA?
RenovoRx, Inc. Common Stock's EBITDA is -$11.5M, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's Diluted EPS (TTM)?
RenovoRx, Inc. Common Stock's Diluted EPS (TTM) is -0.27, based on as-reported figures from SEC (XBRL) filings.
What is RenovoRx, Inc. Common Stock's EBITDA Margin?
RenovoRx, Inc. Common Stock's EBITDA Margin is -584.0%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenues
YoY growth+115.4%+185.8%——
Cost of revenue
Gross profit
% of revenue84.3%85.1%88.2%80.1%
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
% of revenue452.7%701.2%1568.1%1283.1%
Loss from operations
% of revenue-368.4%-616.2%-1479.8%-1203.0%
Other income (expense), net
Interest income, net
Loss of disposition of assets———
Change in fair value of common warrant liability
Total other income (expense), net
Net loss
Net loss per share - basic
Net loss per share - diluted